L. Arvanitakis et al., CONSTITUTIVELY SIGNALING G-PROTEIN-COUPLED RECEPTORS AND HUMAN-DISEASE, Trends in endocrinology and metabolism, 9(1), 1998, pp. 27-31
Dysregulation of G-protein-coupled receptor (GPCR) function has been s
hown to be associated with a growing number of human diseases. In some
diseases, mutation of an endogenous GPCR causes the receptor to lose
the ability to bind agonist or signal ('loss of function' mutation), w
hereas another mutation causes the receptor to be in an active state i
n the absence of agonist ('gain of function' mutation), leading to 'co
nstitutive signaling activity: A number of constitutively active GPCRs
are tumorigenic in vitro and in animal models, and cause syndromes of
hyperfunction and/or tumors in humans. The recent characterization of
a constitutively active GPCR in the genome of a disease-associated, h
uman herpesvirus provides a potential novel mechanism for viral tumori
genesis.